Targeted therapy involves drugs designed to target specific genes or proteins that are involved in the growth and survival of cancer cells. Unlike traditional chemotherapy, which affects all rapidly dividing cells, targeted therapy aims to block the growth of cancer cells with minimal damage to normal cells. Examples include tyrosine kinase inhibitors like imatinib and monoclonal antibodies such as trastuzumab.